Pfizer Inc (PFE) 28.04 $PFE
Most active New York Stock Exchange-traded stocks
AP - Thu Aug 07, 5:14PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Thu Aug 07, 5:14PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Thu Aug 07, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats
at Investor's Business Daily - Thu Aug 07, 11:04AM CDT
Earnings reports from specialty drugmakers continued to roll in Thursday, as two leading stocks stumbled in the early going on the stock market today. Danish diabetes giant Novo Nordisk (NVO) reported Q2 profit of 2.66 kroner (42 cents) a share, up...
Early Glance: Pharmaceuticals companies
AP - Thu Aug 07, 9:59AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Illinois gets $1.3 million in Pfizer settlement
AP - Thu Aug 07, 8:49AM CDT
CHICAGO (AP) — Illinois will receive $1.3 million as part of a $35 million settlement with a Pfizer Inc. over the marketing of an organ-transplant drug.
NY gets $1.7 million in drug settlement
AP - Thu Aug 07, 8:48AM CDT
ALBANY, N.Y. (AP) — New York is getting $1.7 million as its share of a $35 million multi-state settlement with pharmaceutical giant Pfizer Inc. over the marketing of the drug Rapamune.
SD to get $419K from drug company settlement
AP - Thu Aug 07, 8:46AM CDT
PIERRE, S.D. (AP) — Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with Pfizer Inc.
Oregon get $1.2 million in drug settlement
AP - Thu Aug 07, 8:35AM CDT
PORTLAND, Ore. (AP) — Oregon will receive $1.2 million as part of a $35 million settlement with a pharmaceutical giant over the marketing of one of its drugs.
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13(R)1 For Prevention Of Pneumococcal Pneumonia In Adults
Business Wire - Thu Aug 07, 7:01AM CDT
Pfizer Inc. (NYSE
FE) announced today that the European Medicines Agency (EMA) has accepted Pfizer's application seeking to expand the indication for Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults to include the prevention of pneumonia caused by the 13 pneumococcal serotypes contained in the vaccine.
AG Gansler Secures $35 Million Settlement with Pfizer Company illegally promoted post-kidney transplant surgery drug Rapamune
M2 - Thu Aug 07, 4:52AM CDT
Attorney General Douglas F. Gansler announced today that Maryland, joined by 41 other states, reached a $35 million settlement with Pfizer, Inc., to resolve allegations that its subsidiary, Wyeth Pharmaceuticals, Inc., unlawfully promoted Rapamune, an immunosuppressive drug currently approved by the FDA for use in preventing organ rejection after kidney transplant surgery.
Business Highlights
By The Associated Press - AP - Wed Aug 06, 5:14PM CDT
___
Pfizer to pay $35M to settle drug marketing case
AP - Wed Aug 06, 4:08PM CDT
WASHINGTON (AP) — Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.
Walgreen Leads Sell-Off In 'Tax Inversion' Stocks
at Investor's Business Daily - Wed Aug 06, 9:15AM CDT
Walgreen (WAG) will keep its headquarters in America and won't pursue an "inversion" to lower its taxes with the purchase of U.K. pharmacy Alliance Boots. The U.S. pharmacy said the new Walgreens Boots Alliance will be headquartered in the Chicago...
Obama seeks executive ways to limit tax inversions
By JOSH LEDERMAN - AP - Tue Aug 05, 6:11PM CDT
WASHINGTON (AP) — Aiming to sidestep a logjam in Congress, the Obama administration is looking for steps it could take on its own to prevent American companies from reincorporating overseas to shirk U.S. taxes, officials said Tuesday.
Drugmaker AstraZeneca Returns To Growth
at Investor's Business Daily - Tue Aug 05, 4:22PM CDT
British drugmaker AstraZeneca (AZN) has turned the corner after seeing its earnings fall for five straight quarters. In late July, the company delivered second-quarter earnings of $1.30 a share, up 8% from a year ago. Profit fell 17% to 28% in the...
Look for Shares of Pfizer to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 3:47PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $28.29 to a high of $28.71. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.60 on volume of 27.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Most active New York Stock Exchange-traded stocks
AP - Thu Aug 07, 5:14PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Thu Aug 07, 5:14PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Thu Aug 07, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats
at Investor's Business Daily - Thu Aug 07, 11:04AM CDT
Earnings reports from specialty drugmakers continued to roll in Thursday, as two leading stocks stumbled in the early going on the stock market today. Danish diabetes giant Novo Nordisk (NVO) reported Q2 profit of 2.66 kroner (42 cents) a share, up...
Early Glance: Pharmaceuticals companies
AP - Thu Aug 07, 9:59AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Illinois gets $1.3 million in Pfizer settlement
AP - Thu Aug 07, 8:49AM CDT
CHICAGO (AP) — Illinois will receive $1.3 million as part of a $35 million settlement with a Pfizer Inc. over the marketing of an organ-transplant drug.
NY gets $1.7 million in drug settlement
AP - Thu Aug 07, 8:48AM CDT
ALBANY, N.Y. (AP) — New York is getting $1.7 million as its share of a $35 million multi-state settlement with pharmaceutical giant Pfizer Inc. over the marketing of the drug Rapamune.
SD to get $419K from drug company settlement
AP - Thu Aug 07, 8:46AM CDT
PIERRE, S.D. (AP) — Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with Pfizer Inc.
Oregon get $1.2 million in drug settlement
AP - Thu Aug 07, 8:35AM CDT
PORTLAND, Ore. (AP) — Oregon will receive $1.2 million as part of a $35 million settlement with a pharmaceutical giant over the marketing of one of its drugs.
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13(R)1 For Prevention Of Pneumococcal Pneumonia In Adults
Business Wire - Thu Aug 07, 7:01AM CDT
Pfizer Inc. (NYSE
FE) announced today that the European Medicines Agency (EMA) has accepted Pfizer's application seeking to expand the indication for Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults to include the prevention of pneumonia caused by the 13 pneumococcal serotypes contained in the vaccine. AG Gansler Secures $35 Million Settlement with Pfizer Company illegally promoted post-kidney transplant surgery drug Rapamune
M2 - Thu Aug 07, 4:52AM CDT
Attorney General Douglas F. Gansler announced today that Maryland, joined by 41 other states, reached a $35 million settlement with Pfizer, Inc., to resolve allegations that its subsidiary, Wyeth Pharmaceuticals, Inc., unlawfully promoted Rapamune, an immunosuppressive drug currently approved by the FDA for use in preventing organ rejection after kidney transplant surgery.
Business Highlights
By The Associated Press - AP - Wed Aug 06, 5:14PM CDT
___
Pfizer to pay $35M to settle drug marketing case
AP - Wed Aug 06, 4:08PM CDT
WASHINGTON (AP) — Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.
Walgreen Leads Sell-Off In 'Tax Inversion' Stocks
at Investor's Business Daily - Wed Aug 06, 9:15AM CDT
Walgreen (WAG) will keep its headquarters in America and won't pursue an "inversion" to lower its taxes with the purchase of U.K. pharmacy Alliance Boots. The U.S. pharmacy said the new Walgreens Boots Alliance will be headquartered in the Chicago...
Obama seeks executive ways to limit tax inversions
By JOSH LEDERMAN - AP - Tue Aug 05, 6:11PM CDT
WASHINGTON (AP) — Aiming to sidestep a logjam in Congress, the Obama administration is looking for steps it could take on its own to prevent American companies from reincorporating overseas to shirk U.S. taxes, officials said Tuesday.
Drugmaker AstraZeneca Returns To Growth
at Investor's Business Daily - Tue Aug 05, 4:22PM CDT
British drugmaker AstraZeneca (AZN) has turned the corner after seeing its earnings fall for five straight quarters. In late July, the company delivered second-quarter earnings of $1.30 a share, up 8% from a year ago. Profit fell 17% to 28% in the...
Look for Shares of Pfizer to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 3:47PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $28.29 to a high of $28.71. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.60 on volume of 27.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. 
